拓展DNA特异性核酸外切酶TREX1变异在血栓性微血管病中的遗传病因谱
该回顾性计算机模拟研究纳入53例血栓性微血管病(TMA)、94例伴微血管病性病变的IgA肾病、25例C3肾小球病和20例ANCA相关性血管炎患者,发现TREX1致病性变异在TMA中占5.7%、在伴微血管病性病变的IgA肾病中占3.2%,而在C3肾小球病和ANCA相关性血管炎中未发现。研究提示TREX1变异在微血管疾病中具有重要性,尤其与TMA和IgA肾病相关。
要点
- TREX1致病性变异见于5.7%的TMA患者和3.2%的伴微血管病性病变的IgA肾病患者。
- C3肾小球病和ANCA相关性血管炎患者中未发现TREX1致病性变异。
- TREX1在基因组完整性和免疫调节中的作用可能为治疗提供新途径。
核心结论
- 本研究强调TREX1变异在微血管疾病中的重要性,尤其在血栓性微血管病和IgA肾病中。
- TREX1在基因组完整性和免疫调节中的关键作用可能为治疗提供新途径。
研究设计与样本
- 回顾性计算机模拟研究,纳入53例TMA、94例伴微血管病性病变的IgA肾病、25例C3肾小球病和20例ANCA相关性血管炎患者。
主要发现
- TREX1致病性变异在TMA患者中占5.7%,在伴微血管病性病变的IgA肾病患者中占3.2%。
- 在C3肾小球病和ANCA相关性血管炎患者中未发现TREX1致病性变异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Thrombotic microangiopathy (TMA) is a complex condition involving endothelial damage and microvascular thrombi. The International Society of Nephrology's aHUS International Forum identified genetic variants as crucial for tailored therapies like plasma exchange and anti-complement therapy. Recent studies suggested that new pathogenic genes beyond complement and coagulation pathways contribute to TMA including TREX1 variants. The protein TREX1, a DNA-specific exonuclease, maintains genome integrity and regulates immune responses by degrading damaged cytosolic DNA. Variants disrupting TREX1's endoplasmic reticulum anchoring can lead to vasculopathy. METHODS: We conducted retrospective in silico studies involving 53 patients with TMA, 94 with IgA nephropathy with microangiopathic lesions, 25 with C3G glomerulopathy and 20 with ANCA-associated vasculitis. RESULTS: Pathogenic variants of TREX1 were found in 5.7% of patients with TMA and 3.2% of patients with IgA nephropathy with microangiopathic lesions, but none in C3 glomerulopathy or ANCA-associated vasculitis. CONCLUSIONS: Our study highlights the importance of TREX1 variants in microvascular diseases, particularly in thrombotic microangiopathy and IgA nephropathy. TREX1's critical role in genome integrity and immune regulation may offer new therapeutic avenues for treatment.
引用
- Song ZR, Liu ZY, Li MS, et al. Expanding the spectrum of genetic causes of DNA-specific exonuclease TREX1 variants in thrombotic microangiopathy. Kidney Int. 2025. PMID: 40383229. doi:10.1016/j.kint.2025.04.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。